In January 2019, Russia imported 797.1 mln RUB worth of pharmaceutical drugs made in the EEU countries (wholesale priced, VAT included), which is in monetary terms 240% higher than that of January 2018. In physical terms, Russia imported 18.2 mln units, which is 260% higher than that of January 2018.

Between January and November 2018, Russia exported 23.5 bln RUB worth of pharmaceutical drugs (customs duties included, exports to the EEU countries excluded), which is in monetary terms 24.5% higher than that of the same period of 2017. In physical terms, the dynamics are -10.3% (473.6 mln units.)

In 2018, Russia imported 64.3 bln RUB worth of veterinary products (free circulation prices), which is in monetary terms 7.8% higher than that in 2017. Feed supplements have the highest import volume in monetary terms (36.5 bln RUB), and the lowest dynamics in monetary terms as well (7.2%.) The import volume of veterinary drugs is 25.9 bln RUB (+8.6% in monetary terms), while that of veterinary APIs is 1.9 bln RUB (+8.1% in monetary terms.)

In 2018, Russia imported 96.5 bln RUB worth of APIs (free circulation prices, VAT included), which is in monetary terms 30.6% higher than that in 2017. However, the dynamics are that high mostly due to higher import prices. In physical terms, the dynamics are -3% (11,900 tons.)

In 2018, Russia imported 531 bln RUB worth of ready-made pharmaceutical drugs (free circulation prices), which is in monetary terms only 1.1% higher than that in 2017, and 105.4 bln RUB worth o in-bulk pharmaceuticals, which is in monetary terms 10.3% higher than that in 2017. Despite the high dynamics of the in-bulk import, the import volume is much lower than that in 2016, when it was 111 bln RUB.